首頁 產業/市場分類 出版商一覽 Email 通知 GII媒體代理會議 公司簡介 聯絡我們
- English Japanese Korean
首頁 > 市場調查報告書 > 生物科技 > 再生醫學 > 生物工程傷口照護:技術、產品、適應症、參與者與未來展望
產業/市場分類
生物科技 (1574)
分子標靶治療學 (131)
生技設備 (354)
生物材料 (53)
生物標記 (155)
以基因為基之藥物開發 (202)
再生醫學 (119)
抗體和免疫 (189)
個人化醫學 (51)
基因治療學和RNAi (102)
市場調查報告書

生物工程傷口照護:技術、產品、適應症、參與者與未來展望

Bioengineered Wound Care: Technology, Products, Indications, Participants & Prospects

出版商 Greystone Research Associates
出版日期 2011年05月 商品編碼 195637
內容資訊 英文  
價格
US $ 3850 PDF by E-mail (Single user license)
US $ 5500 PDF by E-mail (Site license)
US $ 7500 PDF by E-mail (Enterprise license)


生物工程傷口照護:技術、產品、適應症、參與者與未來展望 是由出版商Greystone Research Associates在2011年05月所出版的。 這份英文市場調查報告書價格從美金3850起跳。

簡介

生物工程創傷照護市場由於先進國家的高齡化使慢性創傷的處理數量增加,形成持續不斷的成長,糖尿病等病患皮膚潰爛的主要病因將在未來15年擴大到全球,對於先進創傷治療產品與治療方法的需求也會隨之提高。

本報告針對生物工程創傷照護分類,提供加入的企業分析、技術評價與商業風險因素、市場課題,目錄介紹如下。

摘要整理

最新創傷照護市場動向

  • 全球創傷市場:目前概要
    • 產業構造
      • 主要市場分類
        • 急性創傷
        • 慢性創傷・潰瘍
        • 外科創傷
        • 燙傷
      • 競爭環境
    • 技術市場促進因素
    • 需求因素
    • 患者動向
    • 風險因素

生物工程創傷照護產品分析

  • Alloderm
  • Apligraf
  • Biobrane
  • Dermagraft
  • Epicel
  • Excellarate
  • Gammagraft
  • Graftjacket
  • Integra Dermal Template
  • Oasis
  • PriMatrix
  • Pomogran
  • Repliform
  • Stratograft
  • Strattice
  • Transcyte
  • VCT01

市場部門評價與機會

  • 急性外傷
  • 燙傷
  • 潰瘍
    • 糖尿病潰瘍
    • 壓力潰瘍
    • 静脈性潰瘍

商業部門策略與風險

  • 開發階段轉變因素
  • 資本投資與商品化
  • 可使用技術

市場因素

  • 臨床實驗因素
  • FDA指南
  • 償還
  • 定點照護檢驗流程

加入企業分析

目錄

Abstract

The report profiles companies active in bioengineered wound care therapeutics, and evaluates technology and business risk factors and market issues. This is a market that is experiencing unabated growth, as the aging of populations in developed countries leads to increasing caseloads of chronic wounds due to disease and immobility. With conditions such as diabetes, a major cause of skin ulcers, forecast to grow worldwide during the next fifteen years, demand for advanced wound care products and therapies will flourish. The report provides an easy-to-understand assessment of bioengineered wound care and the impact it will have on the advanced wound management segment of the healthcare industry.

Highlights

  • Analyzes and evaluates the new generation of tissue-engineered and biologically active technologies and products for treating acute and chronic wounds
  • Provides detailed analysis of twenty-two bioengineered wound care products
  • Assesses business risk factors and market issues
  • Forecasts technology and product developments, and projects probable market impact through 2015
  • Profiles bioengineered wound care companies, their product development activity, and strategies

Feature Summary

  • Analyzes twenty commercial bioengineered tissue repair products, their technology, market impact and future prospects
  • Assesses the market position of bioengineered wound care products by indication and segment
  • Analyzes key business model and technology issues including manufacturability, point-of-use factors, and product stability.
  • Assesses business risk factors and market issues
  • Forecasts technology and product developments, and projects market demand by segment through 2015
  • Profiles market sector companies, their product development activity, and business strategies
  • Evaluates the impact of economic, technology, and regulatory factors on tissue engineered skin substitutes

Methodology

Research methodology is based on primary research in the form of in-depth interviews with key market participants, technology developers, distributors, industry experts, and market influencers, a list that includes regulatory officials, industry trade groups, and materials standards organizations.

Primary data is evaluated and normalized against secondary sources including trade journal articles, technical literature, industry publications, company data sheets and published information, and statistical data from government agencies and trade associations.

Forecasts and projections of market demand and future market activity are derived using standard modeling and statistical techniques.

About Greystone Research Associates

Greystone Research Associates is a medical technology consulting firm focused on the areas of medical market strategy, product commercialization, venture development, and market research. We assist medical and healthcare market participants in achieving their business objectives through the creation of detailed development strategies, product commercialization programs, and comprehensive market and technology research and analysis.

Our market research publications are designed, researched and written to provide timely and insightful information and data on focused market segments, with the aim of providing market participants with the essential knowledge to refine and execute their marketing plans and financial targets.

Table of Contents

Executive Summary

Advanced Wound Care Market Dynamics

  • Global Wound Market - the Current Picture
    • Industry Structure
      • Key Market Segments
        • Acute Wounds
        • Refractory Wounds & Ulcers
        • Surgical Wounds
        • Burns
      • Competitive Landscape
    • Technology Market Drivers
    • Demand Factors
    • Patient Demographics
    • Risk Factors

Bioengineered Wound Care Product Analysis

  • Alloderm
  • Apligraf
  • Biobrane
  • Dermagraft
  • Epicel
  • Excellarate
  • Gammagraft
  • Graftjacket
  • Integra Dermal Template
  • Oasis
  • PriMatrix
  • Pomogran
  • Repliform
  • Stratograft
  • Strattice
  • Transcyte
  • VCT01

Market Sector Assessments & Opportunities

  • Acute Trauma
  • Burns
  • Ulcers
    • Diabetic Ulcers
    • Pressure
    • Venous Ulcers

Business Sector Strategies and Risks

  • Development Stage Transition Factors
  • Capitalization and Commercialization
  • Enabling Technologies

Market Factors

  • Clinical Trial Factors
  • FDA Guidelines
  • Reimbursement
  • Point-of-Care Processing

Market Participant Profiles

Back to Top